UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$425M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$375M |
| 3 |
CRH
CRH
|
+$264M |
| 4 |
Advanced Micro Devices
AMD
|
+$216M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$205M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$523M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$455M |
| 3 |
Financial Select Sector SPDR Fund
XLF
|
+$382M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
UnitedHealth
UNH
|
+$320M |
Sector Composition
| 1 | Technology | 16.51% |
| 2 | Financials | 8.9% |
| 3 | Healthcare | 8.35% |
| 4 | Consumer Discretionary | 6.66% |
| 5 | Industrials | 5.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
4276
LCNB Corp
LCNB
$227M
| $201K | ﹤0.01% |
14,082
-418
| -3% | -$5.97K |
|
4277
Xenon Pharmaceuticals
XENE
$2.85B
| $201K | ﹤0.01% |
5,882
+1,003
| +21% | +$34.3K |
|
4278
MidWestOne Financial Group
MOFG
$609M
| $201K | ﹤0.01% |
9,876
-92
| -0.9% | -$1.87K |
|
|
SHCR
4279
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $201K | ﹤0.01% |
213,574
+14,861
| +7% | +$14K |
|
4280
AST SpaceMobile
ASTS
$12.1B
| $200K | ﹤0.01% |
52,627
-1,729
| -3% | -$6.57K |
|
4281
BioXcel Therapeutics
BTAI
$47.9M
| $199K | ﹤0.01% |
4,913
-2,021
| -29% | -$81.8K |
|
4282
PLAYSTUDIOS Inc
MYPS
$125M
| $198K | ﹤0.01% |
62,351
-6,045
| -9% | -$19.2K |
|
4283
ClearPoint Neuro
CLPT
$318M
| $198K | ﹤0.01% |
39,573
-3,988
| -9% | -$20K |
|
4284
iShares Morningstar Multi-Asset Income ETF
IYLD
$122M
| $198K | ﹤0.01% |
10,397
-200
| -2% | -$3.81K |
|
4285
RCM Technologies
RCMT
$203M
| $195K | ﹤0.01% |
10,004
-4,088
| -29% | -$79.9K |
|
4286
1-800-Flowers.com
FLWS
$352M
| $195K | ﹤0.01% |
27,823
+8,172
| +42% | +$57.2K |
|
4287
Vertex
VERX
$4.01B
| $195K | ﹤0.01% |
8,428
-2,763
| -25% | -$63.8K |
|
4288
Vista Energy
VIST
$3.51B
| $194K | ﹤0.01% |
6,393
-13,846
| -68% | -$421K |
|
4289
dLocal
DLO
$4.4B
| $194K | ﹤0.01% |
10,122
-30,752
| -75% | -$590K |
|
|
NCV
4290
Virtus Convertible & Income Fund
NCV
$345M
| $194K | ﹤0.01% |
15,575
-3,435
| -18% | -$42.7K |
|
4291
Invesco DB Energy Fund
DBE
$49.1M
| $194K | ﹤0.01% |
8,271
+290
| +4% | +$6.79K |
|
4292
MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038
FNGD
$57.8M
| $193K | ﹤0.01% |
1,954
-34
| -2% | -$3.37K |
|
|
SRV
4293
NXG Cushing Midstream Energy Fund
SRV
$201M
| $193K | ﹤0.01% |
5,317
+366
| +7% | +$13.3K |
|
4294
Nature's Sunshine
NATR
$285M
| $193K | ﹤0.01% |
11,628
+1,946
| +20% | +$32.2K |
|
|
AUTL
4295
Autolus Therapeutics
AUTL
$357M
| $192K | ﹤0.01% |
82,310
+12,217
| +17% | +$28.5K |
|
|
WSR
4296
Whitestone REIT
WSR
$649M
| $192K | ﹤0.01% |
19,914
-22,166
| -53% | -$213K |
|
4297
Calavo Growers
CVGW
$490M
| $191K | ﹤0.01% |
7,574
-6,402
| -46% | -$162K |
|
|
HTB
4298
HomeTrust Bancshares
HTB
$730M
| $190K | ﹤0.01% |
8,753
-330
| -4% | -$7.15K |
|
4299
FNB Corp
FNB
$5.85B
| $189K | ﹤0.01% |
17,551
-4,946
| -22% | -$53.4K |
|
4300
Pacific Biosciences
PACB
$381M
| $189K | ﹤0.01% |
22,647
-207,435
| -90% | -$1.73M |
|